These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27793517)

  • 1. A multi-institutional outcome analysis of patients undergoing left ventricular assist device implantation stratified by sex and race.
    Meeteren JV; Maltais S; Dunlay SM; Haglund NA; Beth Davis M; Cowger J; Shah P; Aaronson KD; Pagani FD; Stulak JM
    J Heart Lung Transplant; 2017 Jan; 36(1):64-70. PubMed ID: 27793517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular assist device outcomes based on flow configuration and pre-operative left ventricular dimension: An Interagency Registry for Mechanically Assisted Circulatory Support Analysis.
    Shah P; Birk S; Maltais S; Stulak J; Elmi A; Pagani FD; Cowger JA
    J Heart Lung Transplant; 2017 Jun; 36(6):640-649. PubMed ID: 28087105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular assist device implant in the elderly is associated with increased, but respectable risk: a multi-institutional study.
    Atluri P; Goldstone AB; Kobrin DM; Cohen JE; MacArthur JW; Howard JL; Jessup ML; Rame JE; Acker MA; Woo YJ
    Ann Thorac Surg; 2013 Jul; 96(1):141-7. PubMed ID: 23731606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation.
    Stulak JM; Tchantchaleishvili V; Haglund NA; Davis ME; Schirger JA; Cowger JA; Shah P; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 May; 34(5):718-23. PubMed ID: 25697807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
    Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices: Risk Factors and Outcomes.
    Acharya D; Loyaga-Rendon R; Morgan CJ; Sands KA; Pamboukian SV; Rajapreyar I; Holman WL; Kirklin JK; Tallaj JA
    JACC Heart Fail; 2017 Oct; 5(10):703-711. PubMed ID: 28958345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
    Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
    J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy.
    Stulak JM; Dunlay SM; Sharma S; Haglund NA; Davis MB; Cowger J; Shah P; Masood F; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 Dec; 34(12):1535-41. PubMed ID: 26681123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device.
    Dobarro D; Urban M; Booth K; Wrightson N; Castrodeza J; Jungschleger J; Robinson-Smith N; Woods A; Parry G; Schueler S; MacGowan GA
    J Heart Lung Transplant; 2017 Jan; 36(1):42-49. PubMed ID: 27776988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
    Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
    J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation.
    Stulak JM; Deo S; Schirger J; Aaronson KD; Park SJ; Joyce LD; Daly RC; Pagani FD
    Ann Thorac Surg; 2013 Dec; 96(6):2161-7. PubMed ID: 24035302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender Differences in Outcomes After Implantation of Left Ventricular Assist Devices.
    Ahmed A; Adegbala O; Akintoye E; Inampudi C; Ajam M; Yassin AS; Olawusi E; Shokr M; Alvarez P; Briasoulis A
    Ann Thorac Surg; 2020 Mar; 109(3):780-786. PubMed ID: 31479642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-Operative Right Ventricular Dysfunction Is Associated With Gastrointestinal Bleeding in Patients Supported With Continuous-Flow Left Ventricular Assist Devices.
    Sparrow CT; Nassif ME; Raymer DS; Novak E; LaRue SJ; Schilling JD
    JACC Heart Fail; 2015 Dec; 3(12):956-64. PubMed ID: 26577618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy.
    Katz JN; Jensen BC; Chang PP; Myers SL; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2015 May; 34(5):701-9. PubMed ID: 25582036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.